1720.2000 3.00 (0.17%)
NSE Dec 30, 2025 15:31 PM
Volume: 2.6M
 

1720.20
0.17%
Emkay
Sun’s 2QFY26 EBITDA was ahead of the street and our estimates (by ~12%), on the back of a marginally higher gross margin and lower R&D spend.
Sun Pharmaceutical Industries Ltd. is trading below its 30 day SMA of 1779.4
More from Sun Pharmaceutical Industries Ltd.
Recommended